RS1 rs121913531: Understanding X-Linked Juvenile Retinoschisis
The rs121913531 variant is a rare genetic change located in the RS1 gene. It is associated with X-linked juvenile retinoschisis, a condition that disrupts the structural integrity of the retina and can lead to vision loss.
What each genotype means
Typical retinal structure
You carry two copies of the standard C allele for this variant in the RS1 gene. Research indicates that this genotype produces typical retinoschisin protein, supporting normal structural organization of the retinal cell layers. It is not associated with an increased risk of X-linked juvenile retinoschisis.
Carried by virtually 100% of females across global populations in gnomAD.
Carrier of retinoschisis allele
You carry one copy of the rare pathogenic variant allele and one typical allele on the X chromosome. Because X-linked juvenile retinoschisis typically follows an X-linked recessive inheritance pattern, female carriers generally do not show severe symptoms, though subtle macular changes or mild subclinical findings can occasionally be detected on specialized retinal imaging. Carrier status implies a 50% probability of transmitting the variant allele to offspring.
Extremely rare globally, estimated in fewer than 1 in 100,000 individuals.
Juvenile retinoschisis risk
This genotype indicates two copies of the pathogenic missense variant in the RS1 gene. In published research, this change alters the discoidin domain of retinoschisin and causes X-linked juvenile retinoschisis, characterized by retinal layer splitting, macular cystic cavities, and early-onset central vision loss. Homozygosity in females is extraordinarily rare, but affected individuals present with bilateral macular dystrophy.
Extremely rare worldwide, with documented occurrences restricted to rare consanguineous pedigrees.
What is rs121913531?
The variant rs121913531 is a specific genetic alteration found within the RS1 gene. In genetics, a variant like this represents a change in the DNA sequence compared to the most common version found in the population. This particular variant is classified as a missense mutation, meaning it causes a single amino acid change in the protein produced by the gene. Because the RS1 gene is located on the X chromosome, this variant follows an X-linked inheritance pattern. This means that males, who have only one X chromosome, are primarily affected if they inherit the variant, while females, who have two X chromosomes, are typically carriers who may not show symptoms. This variant specifically disrupts the discoidin domain of the retinoschisin protein, a region critical for the protein's normal function in the eye.
The Role of the RS1 Gene
The RS1 gene provides the instructions for creating a protein called retinoschisin. This protein is essential for the health and maintenance of the retina, the light-sensitive tissue at the back of the eye. Retinoschisin is secreted by retinal cells and acts like a glue, helping to organize and attach retinal cells together. By maintaining this structural organization, the protein ensures that the layers of the retina remain properly aligned. When the RS1 gene is mutated, the resulting retinoschisin protein may be misfolded, unstable, or produced in insufficient quantities. Without functional retinoschisin, the retinal layers can begin to separate, a process known as schisis. This separation creates tiny cavities or tears in the retina, which interferes with the transmission of visual signals to the brain and leads to the vision problems characteristic of X-linked juvenile retinoschisis.
Research and Clinical Evidence
Research into rs121913531 and other RS1 variants is grounded in the study of X-linked juvenile retinoschisis (XLRS). Clinical evidence identifies this variant as pathogenic, meaning it is known to cause the disease. Studies have shown that individuals with pathogenic RS1 mutations often experience a decline in visual acuity during childhood or adolescence, which may stabilize in adulthood before potentially worsening later in life. While gene therapy trials have been conducted to explore potential treatments for XLRS by introducing a functional copy of the RS1 gene into the retina, these trials have faced significant challenges and have not yet met their primary clinical endpoints. Because the evidence for specific outcomes related to this exact variant is limited to its classification as a disease-causing mutation, it is important to rely on clinical genetic testing and consultation with an ophthalmologist for accurate diagnosis and management.
Population Frequency
The rs121913531 variant is extremely rare in the general population. Because it is an X-linked condition, it is almost exclusively identified in males who present with symptoms of retinal dystrophy. Due to its rarity, it is not typically found in large-scale population frequency databases at high percentages. The presence of this variant is usually identified through targeted genetic testing in families with a history of juvenile retinoschisis or in individuals undergoing diagnostic workups for unexplained vision loss. Because the variant is so uncommon, there is no significant data regarding its frequency across different ancestral groups, and it is considered a rare, high-attention variant in clinical genetics.
What You Can Do With This Information
If you or a family member have been identified as having the rs121913531 variant, the most important step is to consult with a medical geneticist or a specialized ophthalmologist. This information is intended for educational purposes and cannot be used to diagnose or treat any condition. Genetic testing results should always be interpreted in the context of a clinical examination, as the presence of a variant does not always predict the exact severity of symptoms. You cannot change your genetic code, but understanding your genetic status can help you and your healthcare team monitor your eye health more effectively. If you are considering clinical trials or new therapeutic approaches, discuss these options with your clinician, as they can provide the most current information on safety, eligibility, and the status of ongoing research in the field of retinal disease.
How common is this variant?
This variant is extremely rare globally, consistent with its status as a pathogenic mutation for an X-linked inherited retinal disease.
Frequently asked questions
Is rs121913531 a common genetic variant?
No, rs121913531 is an extremely rare variant. It is not a common polymorphism found in the general population.
Can I fix the rs121913531 mutation?
Currently, there is no cure for the underlying genetic mutation. While gene therapy research is ongoing, no treatment has yet been proven to fully restore vision in patients with this condition.
Does having this variant mean I will go blind?
The variant is associated with progressive vision loss, but the severity and progression can vary significantly between individuals. You should consult an ophthalmologist to understand your specific prognosis.
Should I get tested for this variant?
Genetic testing is typically recommended if you have symptoms of retinal disease or a family history of X-linked juvenile retinoschisis. Discuss the necessity of testing with a genetic counselor or your doctor.
Sources & further reading
Educational information only, last refreshed 10/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121913531?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in RS1
Encodes the Arg102Gln missense variant in retinoschisin, causing X-linked juvenile retinoschisis with macular splitting and reduced central vision.
An X-linked missense variant in retinoschisin leading to X-linked juvenile retinoschisis and early macular splitting.
Pathogenic splice/missense variant in RS1 implicated in X-linked juvenile retinoschisis with characteristic macular splitting and decreased visual acuity.
An X-linked missense substitution in retinoschisin leading to progressive foveal splitting and early-onset juvenile retinoschisis.
An X-linked missense substitution (p.Glu72Lys) in the retinoschisin gene disrupting discoidin domain function and causing juvenile X-linked retinoschisis.